FDA Warning of Actos Bladder Cancer Risk
The FDA issued an Actos Warning to Patients who have taken the drug Actis( Pioglitazone) for more than a year due an increased risk of Actos bladder cancer based on a newly released study. Actos patients with longer use of Actors have the highest risk of Actos bladder cancer.
Both Germany and France have officially banned use of the drug although Actos is still available in the US. The Actos warning concerning the potentail for bladder cancer will appear on the labeling per the request of the FDA.
Actos controls blood sugar and is sometimes sold in combination with metformin (Actoplus) Met, glimepiride (Duetact).) and Actoplus Met XR. It is estimated that over 2 million people currently use these drugs and need to be warned about the risk of Actos bladder cancer.
Symptoms of Actos Bladder Cancer
The FDA Actos Warning said diabetes patients taking Actos should tell their doctor if they have any of the above symptoms relating to Actos bladder cancer. Patients should talk to their doctors before making any changes to their medicine use and talk to their doctors about any concerns they have with using Actos.
You may be entitled to Compensation
If you or a loved one has been injured as a result of Actos or want to learn more about the Actos warning , contact us now to speak with our qualified Actos Lawyer about possible compensation and information about Actos baldder cancer. Call us now at 877-222-7069 or use the contact form for a free case review.
Actos attorneys at are currently reviewing the potential for Actos bladder cancer lawsuits. If it is proven that these drug manufacturers have placed profits ahead of patient safety by failing to adequately warn users concerning the potential risk of bladder cancer, patients diagnosed with bladder cancer may be compensation through an Actos lawsuit.
The FDA annouced on July 6th, that Stryker has announced a voluntary recall of its modular neck...
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the...
Innovative Surgical, the manufacture of the Da Vinci Surgery Robot recieved a warning letter from FDA...
ATTORNEY ADVERTISEMENT— The information provided on RecallWarning.com is not a substitute for professional medical or legal advice, diagnosis or treatment. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form does not form an attorney-client relationship with the sponsoring attorney. This website is independent of the FDA or any other medical or Govenmental organization. Information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider.
RecallWarning.com is owned and operated by ProSoftLabs
Let Us Help!